Results 61 to 70 of about 339,354 (311)
Introduction to drug utilization research
Research in drug utilization began to develop in the 1960s. Some pioneering studies focused on assessing differences in drug utilization between countries or regions.
Gvozdanović, K +19 more
core +1 more source
Organoids in pediatric cancer research
FEBS Letters, EarlyView.Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley +1 more source
Expert Review of Vaccines, 2018 Introduction: Vaccination is one of the most cost-effective healthcare interventions. Pharmacies in South Africa provide a vaccination service where childhood immunizations, some travel vaccines and vaccines for specific populations are dispensed and ...
Ilse Truter
doaj +1 more source
Introduction to drug utilization research
, 2003 Prepared by the WHO Collaborating Centre for Drug Statistics Methodology, the WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services, and the International Working Group for Drug Statistics Methodology48 p.Korean ...
WHO International Working Group for Drug Statistics Methodology +2 more
core
Comparative drug utilization research comparing different patients
Comparative drug utilization research based on patient characteristics provides a significant contribution to the knowledge on use of drugs in the real world.
von Euler, Mia,, Petrović, Ana Tomas,
core +1 more source
Reciprocal control of viral infection and phosphoinositide dynamics
FEBS Letters, EarlyView.Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley +1 more source
, 2009 This Internet resource contains reports issued throughout multiple yearsKansans Health Policy Authority Medical Programs, Program Assessment for State Fiscal Year 2009 Intervention Outcomes, State Fiscal Year 2010 Kansas Health Policy Authority (KHPA ...
Kansas Drug Utilization Review Board
core
Phosphatidylinositol 4‐kinase as a target of pathogens—friend or foe?
FEBS Letters, EarlyView.This graphical summary illustrates the roles of phosphatidylinositol 4‐kinases (PI4Ks). PI4Ks regulate key cellular processes and can be hijacked by pathogens, such as viruses, bacteria and parasites, to support their intracellular replication. Their dual role as essential host enzymes and pathogen cofactors makes them promising drug targets.
Ana C. Mendes +3 more
wiley +1 more source
Journal of Epidemiology and Global Health, 2018 Antidepressant prescribing patterns have changed globally over the past few years, with conventional drugs including tricyclic antidepressants and monoamine oxidase inhibitors being replaced by selective serotonin reuptake inhibitors (SSRIs) and novel ...
Fatemeh Soleymani +4 more
doaj +1 more source
Drug Utilization Review Program Newsletter Drug Utilization Review Bulletin
, 2009 In 2009 this publication's title changed from Drug Utilization Review Bulletin to Drug Utilization Review Newsletter This internet resource contains several newsletters issued throughout several ...
Kansas. Department of Health and Environment
core